Increased sales potential - Regulatory approval in Japan for aspiration needles opens the second largest IVF market.

2011-10-07 - 15:15

Vitrolife has obtained regulatory approval for the sale of aspiration needles and micro pipettes which are used in infertility treatment (IVF). This means that another important market in Asia can be processed with a higher offer and the total sales potential increases.

"We and many customers who wanted to use even this kind of products from Vitrolife, especially the patented Swemed Sense ™, have been waiting for this for some time. We are very pleased to now offer our Japanese customers our full product range, "says Marcus Hedenskog sales manager Vitrolife KK Japan.

The approval confirms that Vitrolife provides the IVF market with access to safe, effective and compliant product

Gothenburg, October 7, 2011

VITROLIFE AB (publ)

Magnus Nilsson

CEO


Queries should be addressed to:

Magnus Nilsson, CEO, phone +46 31 721 80 61

Anne-Lie Sveder, CFO, phone +46 31 721 80 13